National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting, 88932-88933 [2023-28389]
Download as PDF
<![CDATA[
88932
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
Implementation Working Group of
Council is charged with monitoring and
reporting on implementation of the
recommendations from the PRGLAC.
This includes monitoring and reporting
on implementation, updating
regulations, and guidance, as applicable,
regarding the inclusion of pregnant
women and lactating women in clinical
trials.
The virtual meeting will be held
on January 19, 2023, from 12:00 p.m. to
4:00 p.m. EST.
DATES:
The virtual meeting will be
videocast and can be accessed from the
NIH Videocasting website at https://
videocast.nih.gov/.
ADDRESSES:
For
information concerning this meeting,
Dr. Emma Carpenter, Health Science
Policy Analyst Office of Legislation and
Public Policy, NICHD, NIH, 6710B
Rockledge Drive, Bethesda, MD 20892–
7510, emma.carpenter@nih.gov, 301–
594–2572.
FOR FURTHER INFORMATION CONTACT:
This
notice is pursuant to 42 U.S.C. 285g.
The National Advisory Child Health and
Human Development Council Task
Force on Research Specific to Pregnant
Women and Lactating Women
(PRGLAC) Implementation Working
Group meeting will be open to the
public as a virtual meeting. Individuals
who need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed in
advance of the meeting.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory,
where an agenda and any additional
information for the meeting will be
posted when available.
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Autoimmunity.
Date: January 3, 2024.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xinrui Li, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–2084,
xinrui.li@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28395 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver
National Institute of Child Health and Human
Development, National Institutes of Health.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
[FR Doc. 2023–28445 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:25 Dec 22, 2023
Jkt 262001
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Gene Delivery
Systems for AD/ADRD Therapy
Development.
Date: January 16, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg., Suite
3208, Bethesda, MD 20892, 301–496–3562,
neuhuber@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 20, 2023
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28387 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council, January 10, 2024, 08:30 a.m. to
January 11, 2024, 04:30 p.m., National
Institutes of Health, Building 31, 31
Center Drive, C Wing 6th Floor Conf.
Room F&G, Bethesda, MD, 20892 which
was published in the Federal Register
on September 19, 2023, 88 FR 64448.
This meeting is being amended to
reflect the change in time on the second
day of the meeting, January 11, 2024
from 04:30 p.m. to 12:00 p.m., and to
add the conference room to the meeting
location Building 31, 6th Floor
Conference Room F&G. The meeting is
partially closed to the public.
E:\FR\FM\26DEN1.SGM
26DEN1
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28389 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C Study Section Translational
Neural, Brain, and Pain Relief Devices (NSD–
C).
Date: January 31–February 1, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Bethesda, MD 20892, 301–496–9223,
Ana.Olariu@nih.gov.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–2 Study
Section NINDS K99 and K01.
Date: February 1–2, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Historic Menger Hotel, 204
Alamo Plaza, San Antonio, TX 78205.
Contact Person: DeAnna Lynn Adkins,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive
Blvd., Bethesda, MD 20892, 301–496–9223,
deanna.adkins@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
20:25 Dec 22, 2023
Jkt 262001
DEPARTMENT OF HOMELAND
SECURITY
Dated: December 19, 2023.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
Federal Emergency Management
Agency
[Docket ID FEMA–2023–0002]
Final Flood Hazard Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
BILLING CODE 4140–01–P
National Institutes of Health
VerDate Sep<11>2014
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
[FR Doc. 2023–28331 Filed 12–22–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
88933
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Flood hazard determinations,
which may include additions or
modifications of Base Flood Elevations
(BFEs), base flood depths, Special Flood
Hazard Area (SFHA) boundaries or zone
designations, or regulatory floodways on
the Flood Insurance Rate Maps (FIRMs)
and where applicable, in the supporting
Flood Insurance Study (FIS) reports
have been made final for the
communities listed in the table below.
The FIRM and FIS report are the basis
of the floodplain management measures
that a community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the Federal
Emergency Management Agency’s
(FEMA’s) National Flood Insurance
Program (NFIP).
DATES: The date of May 8, 2024 has been
established for the FIRM and, where
applicable, the supporting FIS report
showing the new or modified flood
hazard information for each community.
ADDRESSES: The FIRM, and if
applicable, the FIS report containing the
final flood hazard information for each
community is available for inspection at
the respective Community Map
Repository address listed in the tables
below and will be available online
through the FEMA Map Service Center
at https://msc.fema.gov by the date
indicated above.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Mapping and Insurance
eXchange (FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
SUPPLEMENTARY INFORMATION: The
Federal Emergency Management Agency
(FEMA) makes the final determinations
listed below for the new or modified
flood hazard information for each
community listed. Notification of these
changes has been published in
newspapers of local circulation and 90
SUMMARY:
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Study Section—A Review of Applications for
Medical Scientist Training Program and
Basic Biomedical Predoctoral T32 awards.
Date: February 20–21, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Isaah S. Vincent, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12L, Bethesda,
Maryland 20892, 301–594–2948,
isaah.vincent@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28393 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Pages 88932-88933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Diabetes and Digestive and Kidney Diseases Advisory Council, January
10, 2024, 08:30 a.m. to January 11, 2024, 04:30 p.m., National
Institutes of Health, Building 31, 31 Center Drive, C Wing 6th Floor
Conf. Room F&G, Bethesda, MD, 20892 which was published in the Federal
Register on September 19, 2023, 88 FR 64448.
This meeting is being amended to reflect the change in time on the
second day of the meeting, January 11, 2024 from 04:30 p.m. to 12:00
p.m., and to add the conference room to the meeting location Building
31, 6th Floor Conference Room F&G. The meeting is partially closed to
the public.
[[Page 88933]]
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28389 Filed 12-22-23; 8:45 am]
BILLING CODE 4140-01-P
